Announced Tue, 26 Aug · 16:20 IST

Scrutinizer''s report of the 34th AGM of the Company for the FY 2024-25 held on 26.08.2025

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Gayatri BioOrganics Ltd held its 34th Annual General Meeting on 26th August 2025 via video conference for FY 2024-25. Six resolutions were put to vote, all of which passed with overwhelming majority — over 99.99% of votes (~3.29 crore shares) were in favor, with only 2 votes cast against across all resolutions. Key items approved include adoption of the audited financial statements for FY25, re-appointment of Mr. Sreedhara Reddy Kanaparthi as Director and as Whole-time Director, appointment of two new Independent Directors (Mr. Srinivas Iduri and Ms. Meenakshi Ramchand Sachdeva), and appointment of M/s. Vivek Surana & Associates as secretarial auditors for a five-year term. The report was issued by S.S Reddy & Associates, Practicing Company Secretaries, and counter-signed by the Whole-time Director.

Likely market impact

Routine procedural filing — all agenda items cleared comfortably with near-unanimous shareholder support, indicating no shareholder dissent on governance or director appointments. No material price action expected.